✦ LIBER ✦

A comparison of the progression of early Parkinson's disease in patients started on ropinirole or L-dopa: an18F-dopa PET study

✍ Scribed by J. S. Rakshi; N. Pavese; T. Uema; K. Ito; P. K. Morrish; D. L. Bailey; D. J. Brooks

Publisher: Springer
Year: 2002
Tongue: English
Weight: 118 KB
Volume: 109
Category: Article
ISSN: 1435-1463
DOI: 10.1007/s00702-002-0753-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rate of progression in Parkinson's disea

Rate of progression in Parkinson's disease: A 6-[18F]fluoro-L-dopa PET study

✍ Elina Nurmi; Hanna M. Ruottinen; Jörgen Bergman; Merja Haaparanta; Olof Solin; P 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

## Abstract The aim of this study was to investigate the rate of progression in Parkinson's disease (PD) with 6‐[^18^F]fluoro‐L‐dopa (FDOPA) positron emission tomography (PET). We investigated 21 patients with PD and eight healthy controls. Ten of the patients were de novo at the time of the first

A follow-up study on 6-[18F]fluoro-L-dop

A follow-up study on 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease shows nonlinear progression in the putamen

✍ Anna Brück; Sargo Aalto; Elina Rauhala; Jörgen Bergman; Reijo Marttila; Juha O. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 1 views

## Abstract Sixteen subjects with de novo Parkinson's disease (PD) underwent three 6‐[18F]fluoro‐L‐dopa (Fdopa) positron emission tomography (PET) scans during a follow‐up time of 5 years (mean ± SD 5.5 ± 0.4 years) to study the progression of striatal dopaminergic hypofunction. Throughout the stud

Direct comparison of FP-CIT SPECT and F-

Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson’s disease and healthy controls

✍ S. A. Eshuis; P. L. Jager; R. P. Maguire; S. Jonkman; R. A. Dierckx; K. L. Leend 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 214 KB

Comparison of FP-CIT SPECT with F-DOPA P

Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson’s disease

✍ S. A. Eshuis; R. P. Maguire; K. L. Leenders; S. Jonkman; P. L. Jager 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 277 KB

Effect of partial volume correction on e

Effect of partial volume correction on estimates of the influx and cerebral metabolism of 6-[18F]fluoro-L-dopa studied with PET in normal control and Parkinson's disease subjects

✍ Olivier G. Rousset; Paul Deep; Hiroto Kuwabara; Alan C. Evans; Albert H. Gjedde; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

A six-month multicentre, double-blind, b

A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled byl-dopa

✍ E. R. Brunt; D. J. Brooks; A. D. Korczyn; J.-L. Montastruc; F. Stocchi; on behal 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 79 KB